---
created: 2025-04-13
updated: 2025-04-13T10:51
id: O]3<Wt2AHV
specialty: neuro
specialty_id: 166
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - source/ak-step1-v11::
  - theme/b&b::17-psych::04-pharm::01-antidepressants
  - source/ak-step1-v11::
  - theme/firstaid::13-psychiatry::02-pathology::45-psychiatric-emergencies::serotonin-syndrome
  - source/ak-step1-v11::
  - theme/firstaid::13-psychiatry::02-pathology::45-psychiatric-emergencies::serotonin-syndrome::treatment
  - source/ak-step1-v11::
  - source/ome-banner::clinical::12-psychiatry::11-catatonia
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::13-psychiatric::01-serotonin-syndrome
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::13-psychiatric::19-ssris
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::13-psychiatric::20-snris
  - source/ak-step1-v11::
  - theme/sketchypharm::06-neuro/psych::03-antidepressants-&-anxiolytics::01-ssris,-snris,-cyproheptadine
  - source/ak-step1-v11::
  - theme/uworld::1000-9999::2000-2999::2089
  - source/ak-step1-v11::^other::^highyield::1-highyield
  - source/ak-step1-v11::^systems::neuro::pharmacology
  - source/ak-step2-v11::!shelf::fm::no-dupes
  - source/ak-step2-v11::!shelf::neuro::no-dupes
  - source/ak-step2-v11::!shelf::psych::no-dupes
  - source/ak-step2-v11::
  - theme/b&b::03-psych::04-psychopharmacology::01-antidepressants::02-mao-inhibitors
  - source/ak-step2-v11::
  - theme/ome::12-psychiatry::11-catatonia
  - source/ak-step2-v11::
  - theme/resources-by-rotation::fm::ome::psych::pharm
  - source/ak-step2-v11::
  - theme/resources-by-rotation::neuro::amboss
  - source/ak-step2-v11::
  - theme/resources-by-rotation::psych::fapsych::pharm
  - source/ak-step2-v11::original-decks::dorian::fam::ome::psych::pharm
  - source/ak-step2-v11::original-decks::dorian::neuro::amboss
  - source/ak-step2-v11::original-decks::dorian::psych::fapsych::pharm"
type: flashcard
---

# Question
**Cyproheptadine::Antihistamine with antiserotonergic properties** is a(n) **5-HT2** receptor antagonist used to treat **serotonin** syndrome

---

# Answer
